AI
| Followers | 843 |
| Posts | 122802 |
| Boards Moderated | 10 |
| Alias Born | 09/05/2002 |
Saturday, July 22, 2006 5:25:15 PM
Actually, NVS has the rights everywhere except the U.S. and Mexico
(They recently licensed the Canadian rights, which DNA had originally retained.) >Novartis will probably rather work with Posurdex than I-vation-TA<
What makes you say this? NVS would have to license Posurdex from AGN.
>But, Genentech might prefer using a platform different from that employed by Novartis to avoid further entanglements with the giant (I don't know, just guessing and hoping).<
I do not understand what you mean by this—please clarify. T.i.a. Dew
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent SRDX News
FEATURED Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • Mar 19, 2026 12:45 PM
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
